136 related articles for article (PubMed ID: 11406641)
1. Her-2/neu gene amplification, elevated mRNA expression, and protein overexpression in the metaplasia-dysplasia-adenocarcinoma sequence of Barrett's esophagus.
Walch A; Specht K; Bink K; Zitzelsberger H; Braselmann H; Bauer M; Aubele M; Stein H; Siewert JR; Höfler H; Werner M
Lab Invest; 2001 Jun; 81(6):791-801. PubMed ID: 11406641
[TBL] [Abstract][Full Text] [Related]
2. [Oncogene amplification and genetic heterogeneity in the metaplasia-dysplasia-adenocarcinoma sequence of Barrett esophagus].
Walch A; Bink K; Hutzler P; Zitzelsberger H; Braselmann H; Aubele M; Höfler H; Werner M
Verh Dtsch Ges Pathol; 2001; 85():257-63. PubMed ID: 11894407
[TBL] [Abstract][Full Text] [Related]
3. TOPOIIalpha and HER-2/neu overexpression/amplification in Barrett's oesophagus, dysplasia and adenocarcinoma.
Rossi E; Villanacci V; Bassotti G; Donato F; Festa A; Cengia G; Grisanti S; Cestari R
Histopathology; 2010 Jul; 57(1):81-9. PubMed ID: 20557373
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of c-erbB-2 overexpression and Her-2/neu gene copy number heterogeneity in Barrett's adenocarcinoma.
Walch A; Bink K; Gais P; Stangl S; Hutzler P; Aubele M; Mueller J; Höfler H; Werner M
Anal Cell Pathol; 2000; 20(1):25-32. PubMed ID: 11007435
[TBL] [Abstract][Full Text] [Related]
5. Fluorescence in situ hybridization mapping of esophagectomy specimens from patients with Barrett's esophagus with high-grade dysplasia or adenocarcinoma.
Brankley SM; Fritcher EG; Smyrk TC; Keeney ME; Campion MB; Voss JS; Clayton AC; Wang KK; Lutzke LS; Kipp BR; Halling KC
Hum Pathol; 2012 Feb; 43(2):172-9. PubMed ID: 21820152
[TBL] [Abstract][Full Text] [Related]
6. Gains and amplifications of c-myc, EGFR, and 20.q13 loci in the no dysplasia-dysplasia-adenocarcinoma sequence of Barrett's esophagus.
Rygiel AM; Milano F; Ten Kate FJ; Schaap A; Wang KK; Peppelenbosch MP; Bergman JJ; Krishnadath KK
Cancer Epidemiol Biomarkers Prev; 2008 Jun; 17(6):1380-5. PubMed ID: 18559552
[TBL] [Abstract][Full Text] [Related]
7. Coamplification and coexpression of GRB7 and ERBB2 is found in high grade intraepithelial neoplasia and in invasive Barrett's carcinoma.
Walch A; Specht K; Braselmann H; Stein H; Siewert JR; Hopt U; Höfler H; Werner M
Int J Cancer; 2004 Dec; 112(5):747-53. PubMed ID: 15386389
[TBL] [Abstract][Full Text] [Related]
8. Chromosomal imbalances in Barrett's adenocarcinoma and the metaplasia-dysplasia-carcinoma sequence.
Walch AK; Zitzelsberger HF; Bruch J; Keller G; Angermeier D; Aubele MM; Mueller J; Stein H; Braselmann H; Siewert JR; Höfler H; Werner M
Am J Pathol; 2000 Feb; 156(2):555-66. PubMed ID: 10666385
[TBL] [Abstract][Full Text] [Related]
9. Increased CDX2 and decreased PITX1 homeobox gene expression in Barrett's esophagus and Barrett's-associated adenocarcinoma.
Lord RV; Brabender J; Wickramasinghe K; DeMeester SR; Holscher A; Schneider PM; Danenberg PV; DeMeester TR
Surgery; 2005 Nov; 138(5):924-31. PubMed ID: 16291394
[TBL] [Abstract][Full Text] [Related]
10. Expression of bile acid transporting proteins in Barrett's esophagus and esophageal adenocarcinoma.
Dvorak K; Watts GS; Ramsey L; Holubec H; Payne CM; Bernstein C; Jenkins GJ; Sampliner RE; Prasad A; Garewal HS; Bernstein H
Am J Gastroenterol; 2009 Feb; 104(2):302-9. PubMed ID: 19174784
[TBL] [Abstract][Full Text] [Related]
11. Early HER2 dysregulation in gastric and oesophageal carcinogenesis.
Fassan M; Mastracci L; Grillo F; Zagonel V; Bruno S; Battaglia G; Pitto F; Nitti D; Celiento T; Zaninotto G; Fiocca R; Rugge M
Histopathology; 2012 Nov; 61(5):769-76. PubMed ID: 22882541
[TBL] [Abstract][Full Text] [Related]
12. No strong association between HER-2/neu protein overexpression and gene amplification in high-grade invasive urothelial carcinomas.
Caner V; Turk NS; Duzcan F; Tufan NL; Kelten EC; Zencir S; Dodurga Y; Bagci H; Duzcan SE
Pathol Oncol Res; 2008 Sep; 14(3):261-6. PubMed ID: 18415713
[TBL] [Abstract][Full Text] [Related]
13. Amplification of Her-2/neu oncogene in GERD - Barrett's metaplasia – dysplasia - adenocarcinoma sequence.
Mokrowiecka A; Wierzchniewska-Lawska A; Smolarz B; Romanowicz-Makowska H; Lochowski M; Kozak J; Malecka-Panas E
Hepatogastroenterology; 2013; 60(125):1063-6. PubMed ID: 23591735
[TBL] [Abstract][Full Text] [Related]
14. HER-2/neu gene amplification by FISH predicts poor survival in Barrett's esophagus-associated adenocarcinoma.
Brien TP; Odze RD; Sheehan CE; McKenna BJ; Ross JS
Hum Pathol; 2000 Jan; 31(1):35-9. PubMed ID: 10665910
[TBL] [Abstract][Full Text] [Related]
15. Her-2 Expression in Gastroesophageal Intestinal Metaplasia, Dysplasia, and Adenocarcinoma.
Almhanna K; Rosa M; Henderson-Jackson E; Jiang K; Shamekh R; Sayegh Z; Malafa MP; Coppola D
Appl Immunohistochem Mol Morphol; 2016 Oct; 24(9):633-638. PubMed ID: 26186253
[TBL] [Abstract][Full Text] [Related]
16. Her-2/neu in barrett esophagus: a comparative study between histology, immunohistochemistry, and fluorescence in situ hybridization.
Rossi E; Villanacci V; Bassotti G; Casa DD; Missale G; Minelli L; Cestari R
Diagn Mol Pathol; 2006 Sep; 15(3):125-30. PubMed ID: 16932066
[TBL] [Abstract][Full Text] [Related]
17. Molecular genetic changes in metastatic primary Barrett's adenocarcinoma and related lymph node metastases: comparison with nonmetastatic Barrett's adenocarcinoma.
Walch AK; Zitzelsberger HF; Bink K; Hutzler P; Bruch J; Braselmann H; Aubele MM; Mueller J; Stein H; Siewert JR; Höfler H; Werner M
Mod Pathol; 2000 Jul; 13(7):814-24. PubMed ID: 10912943
[TBL] [Abstract][Full Text] [Related]
18. Gene amplification of ERBB2 and EGFR in adenocarcinoma in situ and intramucosal adenocarcinoma of Barrett's esophagus.
Ooi A; Zen Y; Ninomiya I; Tajiri R; Suzuki S; Kobayashi H; Imoto I; Dobashi Y
Pathol Int; 2010 Jun; 60(6):466-71. PubMed ID: 20518902
[TBL] [Abstract][Full Text] [Related]
19. Changes in mitochondrial stability during the progression of the Barrett's esophagus disease sequence.
O'Farrell NJ; Feighery R; Picardo SL; Lynam-Lennon N; Biniecka M; McGarrigle SA; Phelan JJ; MacCarthy F; O'Toole D; Fox EJ; Ravi N; Reynolds JV; O'Sullivan J
BMC Cancer; 2016 Jul; 16():497. PubMed ID: 27431913
[TBL] [Abstract][Full Text] [Related]
20. Retinoic acid receptor-alpha messenger RNA expression is increased and retinoic acid receptor-gamma expression is decreased in Barrett's intestinal metaplasia, dysplasia, adenocarcinoma sequence.
Lord RV; Tsai PI; Danenberg KD; Peters JH; Demeester TR; Tsao-Wei DD; Groshen S; Salonga D; Park JM; Crookes PF; Kiyabu M; Chandrasoma P; Danenberg PV
Surgery; 2001 Mar; 129(3):267-76. PubMed ID: 11231454
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
